Relationship Between Thiopurine S-Methyltransferase Genotype/Phenotype and 6-Thioguanine Nucleotide Levels in 316 Patients With Inflammatory Bowel Disease on 6-Thioguanine

por Bayoumy, Ahmed B., Mulder, Chris J. J., Loganayagam, Aathavan, Sanderson, Jeremy D., Anderson, Simon, Boekema, Paul J., Derijks, Luc J. J., Ansari, Azhar R.
Publicado 2021

Therapeutic Drug Monitoring of Vedolizumab in Inflammatory Bowel Disease Patients during Maintenance Treatment—TUMMY Study

por Sivridaş, Merve, Creemers, Rob H., Wong, Dennis R., Boekema, Paul J., Römkens, Tessa E. H., Gilissen, Lennard P. L., van Bodegraven, Adriaan A., Loeff, Floris C., Rispens, Theo, Derijks, Luc J. J.
Publicado 2023

Clinical Outcomes of Covid-19 in Patients With Inflammatory Bowel Disease: A Nationwide Cohort Study

por Derikx, Lauranne A A P, Lantinga, Marten A, de Jong, Dirk J, van Dop, Willemijn A, Creemers, Rob H, Römkens, Tessa E H, Jansen, Jeroen M, Mahmmod, Nofel, West, Rachel L, Tan, Adriaan C I T L, Bodelier, Alexander G L, Gorter, Moniek H P, Boekema, Paul J, Halet, Eric R C, Horjus, Carmen S, van Dijk, Maarten A, Hirdes, Meike M C, Epping Stippel, Ludger S M, Jharap, Bindia, Lutgens, Maurice W M D, Russel, Maurice G, Gilissen, Lennard P L, Nauta, Sjoukje, van Bodegraven, Adriaan A, Hoentjen, Frank
Publicado 2020

Exposure to Thioguanine During 117 Pregnancies in Women With Inflammatory Bowel Disease

por Crouwel, Femke, Simsek, Melek, de Boer, Marjon A, Mulder, Chris J J, van Andel, Emma M, Creemers, Rob H, van Asseldonk, Dirk P, van Bodegraven, Ad A, Horjus, Carmen S, Visschedijk, Marijn C, Weusthuis, Angelique L M, Seinen, Margien L, Jharap, Bindia, van Schaik, Fiona D M, Ahmad, Ishfaq, Boekema, Paul J, Tack, Greetje J, Wormmeester, Louktje, Lutgens, Maurice W M D, van Boeckel, Petra G A, Gilissen, Lennard P L, Kerkhof, Marjon, Russel, Maurice G V M, Hoentjen, Frank, Bartelink, Maartje E, Kuijvenhoven, Johan P, Maljaars, Jeroen W J, van Dop, Willemijn A, Wonders, Janneke, van der Voorn, Michael M P J A, Buiter, Hans J C, de Boer, Nanne K
Publicado 2022

Cost-Effectiveness Analysis of Increased Adalimumab Dose Intervals in Crohn’s Disease Patients in Stable Remission: The Randomized Controlled LADI Trial

por Jansen, Fenna M, van Linschoten, Reinier C A, Kievit, Wietske, Smits, Lisa J T, Pauwels, Renske W M, de Jong, Dirk J, de Vries, Annemarie C, Boekema, Paul J, West, Rachel L, Bodelier, Alexander G L, Gisbertz, Ingrid A M, Wolfhagen, Frank H J, Römkens, Tessa E H, Lutgens, Maurice W M D, van Bodegraven, Adriaan A, Oldenburg, Bas, Pierik, Marieke J, Russel, Maurice G V M, de Boer, Nanne K, Mallant-Hent, Rosalie C, ter Borg, Pieter C J, van der Meulen-de Jong, Andrea E, Jansen, Jeroen M, Jansen, Sita V, Tan, Adrianus C I T L, Hoentjen, Frank, van der Woude, C Janneke
Publicado 2023